Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women (Q35681113)

9 August 2017

Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women (English)

1 reference

9 August 2017

1 reference

M Osaki

1

1 reference

9 August 2017

K Tatsuki

2

1 reference

9 August 2017

T Hashikawa

3

1 reference

9 August 2017

T Norimatsu

4

1 reference

9 August 2017

K Chiba

5

1 reference

9 August 2017

S Motokawa

6

1 reference

9 August 2017

I Furuichi

7

1 reference

9 August 2017

Y Doiguchi

8

1 reference

9 August 2017

K Aoyagi

9

1 reference

9 August 2017

H Shindo

10

1 reference

9 August 2017

language of work or name

English

0 references

publication date

11 March 2011

1 reference

Osteoporosis International

9 August 2017

1 reference

9 August 2017

23

1 reference

9 August 2017

2

1 reference

9 August 2017

695-703

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-011-1556-7

9 August 2017

0 references

cites work

Hip fracture incidence in Japan: estimates of new patients in 2007 and 20-year trends

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261386

Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261386

The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261386

Secular trends in hip fracture incidence and recurrence

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261386

A reference standard for the description of osteoporosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261386

Zoledronic acid and clinical fractures and mortality after hip fracture

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261386

Review of risedronate in the treatment of osteoporosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261386

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261386

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261386

World-wide projections for hip fracture

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261386

Hip fractures in the elderly: a world-wide projection

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261386

A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial

27 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1556-7

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1556-7

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1556-7

Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1556-7

The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1556-7

Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1556-7

Body mass index as a predictor of fracture risk: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1556-7

Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1556-7

Recent trends in the incidence and lifetime risk of hip fracture in Tottori, Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1556-7

Osteoporosis prevention, diagnosis, and therapy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21394496

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. BMD-MN Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21394496

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparative study of potential for bisphosphonates to damage gastric mucosa of rats

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21394496

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00198-011-1556-7

1 reference

9 August 2017

1 reference

9 August 2017

1 reference